RTP’s QHP Capital acquires gene tech firm Applied StemCell
Applied StemCell specializes in cell and gene therapy products and services. QHP’s investment in the company reflects a history of healthcare and pharma investment.
Read More
stem cells
Stem cell research boost: Durham firm, France-based biotech strike testing partnership
KaryoLogic, which is based in Durham, is teaming up with a French biotechnology company to test and analyze chromosomes in human stem cells. Here are the details.
Read More
World Stem Cell Summit coming to Winston-Salem as regenerative medicine gains traction
The 20th World Stem Cell Summit will be held in Winston-Salem on June 5-9, 2023, alongside the tenth year of a regenerative medicine course.
Read More
Engineering stem cells for blood vessel growth is focus of new Duke bioengineering professor
New Duke University Department of Biomedical Engineering faculty member Sharon Gerecht uses biomaterials and other engineered environments to help stem cells evolve into vascular cells, the foundation of blood vessels. Here’s a look at her research.
Read More
FDA scores legal victory in crackdown on stem cell clinics, products
The US Food and Drug Administration won a major legal victory in its ongoing effort to crack down on clinics marketing bogus and potentially hazardous stem cell products.
Read More
Experimental treatment uses modified stem cells to fight cancer
A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient’s own body into a powerful weapon against cancer.
Read More
